Impact of neoadjuvant chemotherapy on surgical outcomes among patients with hormone receptor positive breast cancer.

Andrew N HageChristina CapricciosoJulia BrennanBrendan HeidenAlexander ZheutlinMichael S Sabel

Published in: Journal of surgical oncology (2017)

Despite poor pCR rates, NACT still has potential to improve surgical outcomes among hormone receptor positive patients. The surgical conversion rate is a superior measure of the impact of NACT on surgical decision making than examining BCT rates.

Keyphrases

neoadjuvant chemotherapy
positive breast cancer
end stage renal disease
decision making
ejection fraction
newly diagnosed
locally advanced
lymph node
chronic kidney disease
sentinel lymph node
early stage
risk assessment
climate change
patient reported